Abstract:BACKGROUND AND OBJECTIVE:CD133-positive colon cancer stem like cells (CSLCs) are resistant to the conventional cytotoxic drug 5-fluorouracil (5-FU). Wnt signaling pathway plays important roles in colon cancer carcinogenesis and metastasis, and regulates the self-renewal capacity of CSLCs. In the present study, we explored the impact of 5-FU on Wnt signaling pathway of CD133-positive colon CSLCs, and the relation between Wnt signaling pathway and drug resistance of CD133-positive colon CSLCs.METHODS:Magnetic activation cell separation was used to collect CD133-positive cells from colon cancer cell line DLD1, which was transfected with luciferase reporter for Wnt signaling activity. The activity of Wnt signaling pathway was compared between CD133-positive and CD133-negative cells. After the treatment with 1 μg/mL of 5-FU, the cell proliferation rates of DLD1 cells, CD133-positive cells, and CD133-negative cells were compared. After the treatment with 1 μg/mL and 10 μg/mL of 5-FU for 48 h, Wnt activity was compared between CD133-positive and CD133-negative cells. The expression of CD133 and cell apoptosis of CD133-positive cells was detected after exposure to 50 ng/mL of dickkopf (DKK)-1, a Wnt pathway inhibitor.RESULTS:After the treatment with 5-FU, the cell proliferation rate of CD133-positive cells was higher than that of CD133-negative cells and the sensitivity of CD133-positive cells to 5-FU decreased. Wnt activity was higher in CD133-positive cells than in CD133-negative cells [(46.3 ± 0.3)% vs. (33.9 ± 2.7)%, P = 0.009]. After the treatment with 1 μg/mL and 10 μg/mL of 5-FU, Wnt activity of CD133-positive cells was (90.1 ± 10.0)% (P = 0.012) and (52.9 ± 2.5)% (P = 0.047), respectively, whereas that of CD133-negative cells was (35.5 ± 3.3)% (P = 0.434) and (26.5 ± 0.4)% (P = 0.046), respectively. CD133 expression in CD133-positive cells decreased from (87.2 ± 5.3)% to (60.6 ± 3.1)% (P = 0.022) after treatment with DKK-1, whereas the cell apoptosis rate increased from (11.8 ± 0.2)% to (28.3 ± 0.6)% (P = 0.013).CONCLUSIONS:Wnt activity is higher in CD133-positive DLD1 cells than in CD133-negative DLD1 cells. 5-FU can upregulate Wnt activity of CD133-positive colon CSLCs. Blocking Wnt activity may reverse drug sensitivity of CD133-positive cells to 5-FU.

Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells

HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway.

Establishment of a 5-DFUR-resistant human hepatocellular carcinoma cell model and preliminary study of the mechanisms of the drug resistance]

Possible Mechanisms of Acquired Resistance to 5-FU in Human Colon Cancer

Correction: Dishevelled1-3 Contribute to Multidrug Resistance in Colorectal Cancer Via Activating Wnt/β-catenin Signaling.

5-Fluorouracil Upregulates the Activity of Wnt Signaling Pathway in CD133-positive Colon Cancer Stem-Like Cells

The Upregulation of Dihydropyrimidine Dehydrogenase in Liver is Involved in Acquired Resistance to 5-Fluorouracil.

Linc-Ror Facilitates Hepatocellular Carcinoma Resistance To Doxorubicin By Regulating Twist1-Mediated Epithelial-Mesenchymal Transition

HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance

Wnt Pathway is Involved in 5-FU Drug Resistance of Colorectal Cancer Cells.

The Role of GLI1 for 5-Fu Resistance in Colorectal Cancer

ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer

Proteomic Analysis Reveals That EPHX1 Contributes to 5-Fluorouracil Resistance in a Human Hepatocellular Carcinoma Cell Line.

Targeting DCLK1 Overcomes 5‐fluorouracil Resistance in Colorectal Cancer Through Inhibiting CCAR1/β‐catenin Pathway‐mediated Cancer Stemness

H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA.

Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway

Silencing Dishevelled‐1 Sensitizes Paclitaxel‐resistant Human Ovarian Cancer Cells Via AKT/GSK‐3β/β‐catenin Signalling

Bcl-Xl Small Interfering Rna Suppresses The Proliferation Of 5-Fluorouracil-Resistant Human Colon Cancer Cells

The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.

Interference of Frizzled 1 (FZD1) Reverses Multidrug Resistance in Breast Cancer Cells Through the Wnt/β-catenin Pathway

The PDGF-D/miR-106a/Twist1 Pathway Orchestrates Epithelial-Mesenchymal Transition in Gemcitabine Resistance Hepatoma Cells.